4
Changes in Ownership
ALX ONCOLOGY HOLDINGS INC Filed Acc 0001209191-21-069154
Director sold 145,637 shares at an average $32.26 ($4,698,091)
From the SEC's structured data for this filing
Trades in this filing
Lettmann Jason · Director
Table I: Non-derivative
16 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-08 | Sale : show line 1 in the form | −35,836 | $33.23 | $1,190,830 | 2,232,251 | I |
| 2021-12-08 | Sale : show line 2 in the form | −4,883 | $33.23 | $162,262 | 304,339 | I |
| 2021-12-08 | Sale : show line 3 in the form | −1,531 | $33.80 | $51,748 | 2,230,720 | I |
| 2021-12-08 | Sale : show line 4 in the form | −208 | $33.80 | $7,030 | 304,131 | I |
| 2021-12-09 | Sale : show line 5 in the form | −11,452 | $31.08 | $355,928 | 2,219,268 | I |
| 2021-12-09 | Sale : show line 6 in the form | −1,560 | $31.08 | $48,485 | 302,571 | I |
| 2021-12-09 | Sale : show line 7 in the form | −42,203 | $32.06 | $1,353,028 | 2,177,065 | I |
| 2021-12-09 | Sale : show line 8 in the form | −5,751 | $32.06 | $184,377 | 296,820 | I |
| Open-market sales · 145,637 sh · avg $32.26 · $4,698,091 | ||||||
Loading xslF345X03/doc4.xml…